source
- AI drug-discovery startup Chai Discovery raises $400 million in Series C, tripling its valuationChai Discovery, a startup focused on using artificial intelligence for drug discovery, announced a new Series C financing round that brought in $400 million. The capital injection was led by existi…
- Biogen's tau therapy shows mixed Alzheimer's results, low dose outperforms higher doseAt the Alzheimer's Association International Conference in London, Biogen presented data on its experimental tau‑targeting therapy for Alzheimer's disease. The trial showed that the drug produced…